Covid-19 and Kidney Transplantation

• Published in: The New England journal of medicine Vol. 382; no. 25; pp. 2475 - 2477
• Main Authors: Akalin, Enver, Azzi, Yorg, Bartash, Rachel, Seethamraju, Harish, Parides, Michael, Hemmige, Vagish, Ross, Michael, Forest, Stefanie, Goldstein, Yitz D, Ajaimy, Maria, Liriano-Ward, Luz, Pynadath, Cindy, Loarte-Campos, Pablo, Nandigam, Purna B, Graham, Jay, Le, Marie, Rocca, Juan, Kinkhabwala, Milan
• Format: Journal Article
• Language: English
• Published: United States Massachusetts Medical Society 18.06.2020
• Subjects: Adult; Aged; Betacoronavirus; CD3 antigen; CD4 antigen; CD8 antigen; Coronavirus Infections - complications; Coronavirus Infections - mortality; Coronavirus Infections - physiopathology; Coronaviruses; Correspondence; COVID-19; Cytokines; Female; Fever; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mortality; New York City; Pandemics; Pneumonia, Viral - complications; Pneumonia, Viral - mortality; Pneumonia, Viral - physiopathology; Risk Factors; SARS-CoV-2; Transplant Recipients; Transplants & implants; New York City

A cohort of 36 consecutive kidney-transplant recipients had less fever, lower CD3, CD4, and CD8 cell counts, more rapid clinical deterioration, and a higher mortality than the general population of patients with Covid-19.